Skip to main content

Support for scientific communication in the humanities, social sciences, and public health - Médéric Alzheimer Foundation (FMA) - Applications accepted on a rolling basis through the FMA throughout the current calendar year (2026)

Posted on June 12, 2026

Calenda Announcement 1 396 447 (excerpts)

To encourage young researchers and doctoral students to showcase their research in the humanities, social sciences, or public health related to Alzheimer’s disease, the Médéric Alzheimer Foundation is offering support for participation in a scientific presentation through a call for applications.

Overview

This support is intended for students enrolled in a doctoral program in the humanities and social sciences (psychology, sociology, economics, law, anthropology, demography, philosophy, linguistics, political science, education, nursing, etc.) or public health at a French university in 2025–2026 whose research focuses on Alzheimer’s disease.

The support covers a scientific presentation at one of the proposed events or at a conference of the candidate’s choice within their discipline and will take the form of a contribution toward conference registration fees, accommodation, and/or travel expenses, up to a maximum of €5,000 upon submission of receipts.

Only one application per young researcher will be accepted. If the presentation is not selected, the funding may be used for another event, provided that this event was mentioned at the time of application; otherwise, reimbursement of the amount will be required.

In practice 

  • Applies to a scientific presentation at an event or conference of the applicant’s choice within their discipline. 
  • Will take the form of a contribution toward covering expenses (registration, accommodation, and/or travel).
  • Only one application per young researcher will be accepted

Eligibility

  • Must be enrolled in a doctoral program in the humanities and social sciences or public health at a French university.
  •  The research must fall within the field of cognitive aging and focus on Alzheimer’s disease.